envelope graphic E-mail page  



Neuroblastoma is a solid, cancerous tumor that begins in the sympathetic nervous system. This type of tumor often is found in the abdomen, but can also be located in the neck, chest and/or pelvis. Most children with neuroblastoma are diagnosed before the age of five.

The Neuroblastoma Program at the University of Chicago Medicine Comer Children's Hospital is led by Susan Cohn, MD, one of the nation's foremost authorities on neuroblastoma. Under Dr. Cohn's leadership, a team of pediatric cancer experts provides comprehensive diagnoses and a wide range of advanced treatment options.

At the Forefront of Neuroblastoma Therapies

At the Forefront of Neuroblastoma Therapies

Our physicians are very active in the Children's Oncology Group (COG), the New Approaches to Neuroblastoma Therapy (NANT) consortium, and the Advances in Neuroblastoma Research Association. As a result, our patients have access to some of the latest treatments. Participation in these organizations also helps our physicians stay informed about advances in neuroblastoma care as they develop. In fact, our experts often are involved in improving current treatments and identifying options for tumors that do not respond to conventional therapies. » Learn more about neuroblastoma research and clinical trials.

More Information

» Diagnosis and Treatment of Neuroblastoma
» I131-MIBG Therapy for Neuroblastoma
» Neuroblastoma Research and Clinical Trials
» Our Neuroblastoma Team
» Neuroblastoma Resources and Support

MyChart | CareLink | Notice of Privacy Practices | Financial Assistance | Legal Disclaimer | JCAHO Public Notice | Contact Us | Site Map

The University of Chicago Medicine Comer Children's Hospital  |   5721 S. Maryland Avenue   |   Chicago, IL 60637